Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Isotope & Radiation Corp. ( (HK:1763) ) has provided an update.
China Isotope & Radiation Corporation has announced the composition of its board of directors, detailing the roles and functions of each member. The board includes executive, non-executive, and independent non-executive directors, who are also part of various committees such as the Nomination Committee, Remuneration and Appraisal Committee, Audit and Risk Management Committee, Strategy Committee, Legal Affairs Committee, and Science and Technology Innovation Committee. This announcement reflects the company’s structured governance approach and highlights the diverse expertise of its board members, potentially strengthening its strategic and operational decision-making processes.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation is a company based in the People’s Republic of China, operating in the isotope and radiation industry. The company focuses on providing products and services related to isotopes and radiation technologies.
YTD Price Performance: 19.71%
Average Trading Volume: 169,373
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.16B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.